Currently, propofol is widely used as an intravenous anesthetic and sedative in clinical settings. Propofol is hardly soluble in water in nature and is prescribed as an emulsion formulation containing soybean oil, glycerin, and egg phospholipids.
Currently, propofol is widely used as an intravenous anesthetic and sedative in clinical settings. Propofol is hardly soluble in water in nature and is prescribed as an emulsion formulation containing soybean oil, glycerin, and egg phospholipids. 1) As a result, the long-term use of a propofol emulsion, for example in post-operative sedation, may not only lead to overload of the fat nutrition 2) but also an increase in the risk of infection in patients by rapid microbial growth at room temperature. 3) In addition, clinical problems that have been noted with propofol include vascular pain on injection 4) and strong respiratory depression. 5) Based on the points above-mentioned, aiming at the discovery of an anesthetic and sedative as an easy-to-formulate water-soluble drug with reduced respiratory depression, we initiated a search for a compound suitable as a lead. Recently nonbenzodiazepine compounds with selective pharmacological actions on sedation and anti-anxiety have been developed. 6, 7) Therefore, amongst the parent skeletons of these nonbenzodiazepine compounds, we took note of the isoindolin-1-one skeleton 6) ( Fig. 1) , and synthesized approximately 170 compounds and evaluated their hypnotic effects in mice after intravenous administration. 8 ) Herein, we report the representative preferred compounds with potent sedative-hypnotic actions.
Chemistry
The general synthetic method used to prepare isoindolin-1-one derivatives is as shown in Chart 1. Phthalic anhydride 30 was heated with an appropriate amine to afford phthalimides 31, which were then reduced with sodium borohydride to afford the hemiacetals 32. The hemiacetals 32 and the Wittig reagent (Ph 3 PϭCHCO 2 Et) were heated in toluene to afford the ethyl esters 33, which were then hydrolyzed with potassium carbonate to afford the carboxylic acids 34. In the presence of N-(3-dimethylaminopropyl)-NЈ-ethylcarbodiimide hydrochloride and HOBT (1-hydroxybenzotriazole hydrate), reaction with the appropriate 1-alkylpiperazine 35 afforded the isoindolin-1-one derivatives 1-14, 22-26. In the presence of N-(3-dimethylaminopropyl)-NЈ-ethylcarbodiimide hydrochloride and 4-dimethylaminopyridine, carboxylic acid 34 was reacted with an appropriate alcohol to afford esters 17 and 18. Heating of hemiacetal 32 with 1-(triphenylphosphoranylidene)-2-propanone afforded ketone 19.
The starting material, phthalic anhydride 30 was synthesized in only a few steps and with high efficiency by the route shown in Chart 2. Specifically, the addition reaction of 2,3-dimethyl-1,3-butadiene 36 and maleic anhydride afforded acid anhydride 37, which was then heated with bromine in acetic acid and converted into phthalic anhydride 30.
The 1-alkylpiperazines 35 were synthesized based on the literature 9) as shown in Chart 3. Specifically, ethyl 1-piperazinecarboxylate 38 and an appropriate alkyl halide were heated in the presence of potassium carbonate to afford ethyl esters 39, which were then heated with 47% hydrogen bromide to afford hydrobromides 40, which were then treated with sodium hydroxide to afford the 1-alkylpiperazines 35.
Ethers 20 and 21 were synthesized by the methods shown in Chart 4. Specifically, ester 33b was reduced by heating with excess sodium borohydride to afford alcohol 41, which was then reacted with methanesulfonyl chloride and transformed into methanesulfonyloxy 42. Heating the methanesulfonyloxy 42 with sodium methoxide, prepared from methanol and sodium, or with the commercially available reagent sodium ethoxide afforded ethers 20 and 21, respectively.
The 5,6-position cyclized compounds 27-29 were prepared using the phthalic anhydrides 43a-c shown in Chart 5, and using the same method as shown in Chart 1. The phthalic anhydrides 43a-c were synthesized as described below. First, 1,6-heptadiyne 44a, 1,7-octadiyne 44b, and propargyl ether 44c were heated with diethyl acetylenedicarboxylate in the presence of dicarbonylcyclopentadienyl cobalt(I) to afford diesters 45a-c, which were then treated with hydrochloric acid or potassium carbonate to afford dicarboxylic acids 46a-c. Finally, heating them in acetic anhydride gave the desired phthalic anhydrides 43a-c.
Synthesis of the enantiomers of 5 was achieved by the method described below. First, the racemic carboxylic acid 34 shown in Chart 1 was reacted with (S)-(Ϫ)-1-phenylethylamine to form the salt, which was then repeatedly recrystallized from methanol or ethanol. The obtained crystals were treated with diluted hydrochloric acid to obtain the (Ϫ) form of the carboxylic acid. This carboxylic acid 34(Ϫ) was reacted, as in Chart 1, with 1-methylpiperazine to obtain the (Ϫ) form of 5. The resolving agent (R)-(ϩ)-1-phenylethylamine was used in the same way to obtain the (ϩ) form of 5. The (Ϫ) forms of 3, 27, and 47 (JM-1232) were prepared in a similar way.
Results and Discussion
We first synthesized isoindolin-1-one derivatives in racemic form. We introduced a phenyl group to the 2-position and chloro, methyl, and nitro groups to the 5-position of the isoindolin-1-one skeleton, and in order to increase the water solubility of the compounds as hydrochloride salts, we introduced a substituent at the 3-position in the form of a 2-(4-methyl-1-piperazinyl)-2-oxoethyl group (Fig. 2) . When these compounds were intravenously administered to mice, loss of righting reflex was not obtained and sedation-like action (inhibition of locomotor activity) was observed. Additionally, since even when the chloro group at the 5-position was changed to the 6-position, the same sedation-like action was observed, it was considered that the 5-and 6-position substituents exert some effect on the sedative-hypnotic activity. When chloro groups were introduced to both the 5,6-positions, while the activity was weaker, loss of righting reflex in mice was noted. To further increase the activity of this dichloro compound, the dichloro group was changed to the dimethyl, diethyl, and dimethoxy group, and the dimethyl compound 3 showed potent sedative-hypnotic activity (HD 50 ϭ9.37 mg/kg) ( Table 1) .
In order to increase the activity of 3 further, we next performed a series of synthetic modifications ( Table 1) . Introduction and fixation of a methyl group to the 5,6-positions, and a 2-(4-methyl-1-piperazinyl)-2-oxoethyl group to the 3-position, and introduction of a naphthyl or cyclohexyl to the 2-position in place of the phenyl group, did not show activity at 20 or 40 mg/kg. Thus, the 2-position was fixed as a phenyl group and various substituents were introduced to this phenyl. Initially, a fluorine atom was introduced to the o-, m-, and p-positions, separately, and the m-position substituted compound 5 (HD 50 ϭ6.92 mg/kg) had greater activity than non-substituted compound 3. Since modification of the mposition showed a favorable tendency, other halogen atoms were introduced to the m-position, but activity was lower than for 3. Furthermore, various electron-releasing and electron-withdrawing groups were introduced to this m-position, but these derivatives also had weaker activity. Moreover, the difluoro derivative 14 was synthesized by introduction of a fluorine atom to both m-positions, but activity was weaker than for the mono-substituted m-position derivative 5. Therefore, it was judged that the most effective 2-position modification was an unsubstituted phenyl or a m-fluoro phenyl group.
Next, we attempted to optimize the 3-position substituent of the isoindolin-1-one skeleton. The combination of a 2-position hydrophobic group and a 3-position hydrophilic group was inverted. In other words, derivatives with hydrophilicity at the 2-position and hydrophobicity at the 3-position were synthesized ( Table 2 ). In this case, a pyridine ring was selected for the 2-position hydrophilic group, and compounds 33b and 16 were synthesized, and we examined which was the optimal 2-position substituent, a 3-pyridyl or a 4-pyridyl group. As a result, since the 3-pyridyl analog showed a hypnotic effect, the 2-position substituent was fixed as 3-pyridyl and various ester, ketone, and ether groups were introduced as the 3-position hydrophobic group (compounds 17-21). However, no compounds with better activity than 5 and 3 were found. Therefore, since the combination of a 2-position hydrophobic group and a 3-position hydrophilic group gave the most favorable results, modification of the terminal methyl group of the 3-position substituent piperazine of 5 and 3 into a bulky substituent was next examined (Table 3) . However, no compounds with stronger activity than 5 and 3 1684 Vol. 55, No. 12 were found.
Furthermore, we fixed the 2-position as m-fluoro phenyl and the 3-position as a 2-(4-methyl-1-piperazinyl)-2-oxoethyl group and modified the 5,6-position dimethyl group into a cyclized structure (Table 4) . As a result, the five-membered ring compound 27 was shown to have good activity.
On the other hand, we performed optical resolution of 5, which showed high activity in the racemic form and evaluated the activity and toxicity of the (ϩ) and (Ϫ) isomers. As shown in Table 5 , the activity of the (Ϫ) enantiomer 5(Ϫ) was increased by more than 3-fold compared to that of the racemic form. Additionally, it showed low toxicity, with LD 50 ϭ64.69 mg/kg, and the therapeutic index (LD 50 /HD 50 ) value of 34.05 was 10-times better than that for propofol (HD 50 ϭ11.88 mg/kg, LD 50 ϭ40.45 mg/kg, LD 50 /HD 50 ϭ3.40).
10) Thus, since for 5, the (Ϫ)-enantiomer showed a superior result, the (Ϫ)-enantiomer of 3 was also synthesized. As a result, since activity was more than 3 times better compared to the racemic form, the (Ϫ) forms of the 5,6-position cyclized compound 27 and the non-fluoro compound 47 (JM-1232) (Fig. 3) were also synthesized and their activity and toxicity were evaluated. As shown in Table 5 , as well as maintenance of potent activity with 27(Ϫ) and 47(Ϫ) [JM-1232(Ϫ)], their toxicity was further reduced, with LD 50 Ͼ120 mg/kg, compared to before cyclization, and the therapeutic indexes (LD 50 /HD 50 ) were Ͼ55.30 and Ͼ38.46, respectively, which were good values.
Conclusion
Synthetic studies on a series of isoindolin-1-one derivatives have led to the discovery of various compounds that showed sedative-hypnotic effects in mice after intravenous administration. Amongst them, 5 and 3 in racemic form showed strong activity (HD 50 ϭ6.92 mg/kg and HD 50 ϭ 9.37 mg/kg, respectively). The hypnotic effects of 5 and 3 were enantioselective and the (Ϫ)-enantiomers 5(Ϫ) and 3(Ϫ) showed more potent activity (HD 50 ϭ1.90 mg/kg and HD 50 ϭ2.35 mg/kg, respectively). In addition, the 5,6-position cyclized derivatives 27(Ϫ) and 47(Ϫ) [JM-1232(Ϫ)] also showed and retained potent activity (HD 50 ϭ2.17 mg/kg and HD 50 ϭ3.12 mg/kg, respectively) and showed less toxicity in comparison to the 5,6-position dimethyl derivative. In general observation, these 4 compounds did not have the direct action on respiratory rate, but showed the tendency to decrease it in response to the depth of the sedative-hypnotic state. And as a result of the general pharmacological study done afterwards, 47(Ϫ) [JM-1232(Ϫ)] was selected as a candidate for the clinical trial.
Experimental 1 H-NMR spectra were obtained by a Lambda 400 MHz spectrometer (JEOL Ltd., Tokyo, Japan) using Me 4 Si as the internal standard. Mass spectral data were obtained on a ZQ2000 mass spectrometry (Waters, Tokyo, Japan). Silica gel 60 (Merck Ltd., Tokyo, Japan, 230-400 mesh) was used in the column chromatography.
5,6-Dimethyl-2-benzofuran-1,3-dione (30) To a solution of maleic anhydride (5.4 g, 55 mmol) in benzene (50 ml), 2,3-dimethyl-1,3-butadiene 36 (6.3 ml, 55 mmol) was added dropwise and the mixture was then stirred at 25°C overnight. After filtration to remove insoluble material, the filtrate was concentrated under reduced pressure to afford 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione 37 (9.5 g, 96%). To a solution of the obtained 37 (9.5 g, 53 mmol) in CH 3 COOH (28 ml) at 115°C, a solution of bromine (6.1 ml, 0.12 mol) in CH 3 COOH (28 ml) was added dropwise over 45 min and the solution was then heated under reflux for 1 h. After allowing the reaction solution to stand overnight, the precipitate was collected by filtration, washed with diethyl ether and dried to afford 30 (3.5 g, 37%). and it was then extracted with EtOAc and the organic layer was washed with saturated NaCl solution, dried with anhydrous Na 2 SO 4 , and concentrated under reduced pressure. The resulting residue was chromatographed on a silica gel column (elution with CHCl 3 followed by hexane/EtOAcϭ10/1) to give diethyl 5,6-indanedicarboxylate 45a (0.36 g, 22%). To a solution of the obtained 45a (0.36 g, 1.4 mmol) in CH 3 COOH (0.8 ml), concentrated hydrochloric acid (0.4 ml) was added and the mixture was stirred at 80°C overnight. Ice-water was added to the reaction mixture and the resulting precipitate was collected by filtration, washed with water, and dried to afford 5,6-indanedicarboxylic acid 46a (0.28 g, 97%). The obtained 46a (0.28 g, 1.4 mmol) in acetic anhydride (6.7 ml) was heated under reflux overnight. The reaction mixture was poured into ice-water and the precipitate was collected by filtration, washed with water, and dried to afford 43a (0.25 g, 95% In Chart 3, when R 3 is 2-ethylbutyl, the 1-alkylpiperazine 35 is 35a. 1-(2-Ethylbutyl)piperazine (35a) A mixture of ethyl 1-piperazinecarboxylate 38 (1.50 g, 9.48 mmol), 1-bromo-2-ethylbutane (1.59 g, 9.48 mmol), and K 2 CO 3 (1.57 g, 11.38 mmol) in CH 3 CN (30 ml) was stirred for 24 h at 90°C under an argon atmosphere. The reaction mixture was then concentrated under reduced pressure. Water was added to the residue, followed by extraction with CHCl 3 , drying with anhydrous Na 2 SO 4 , and concentration under reduced pressure. The resulting residue was chromatographed on a silica gel column (CHCl 3 /MeOHϭ50/1) to give ethyl 4-(2-ethylbutyl)-1-piperazinecarboxylate 39a (1.90 g, 83%) . The obtained 39a (1.90 g, 7.84 mmol) in 47% HBr (51 ml) was stirred for 3 h at 110°C. The reaction mixture was then concentrated under reduced pressure and the obtained crystals were then washed with diethyl ether, collected by filtration, and dried to afford 1-(2-ethylbutyl)piperazine dihydrobromide 40a (1.87 g, 72%). The obtained 40a (1.87 g, 4.61 mmol) was dissolved in H 2 O (6 ml) and 1N-NaOH was added to adjust to pH 8. MeOH (50 ml) was added to it and insoluble material was removed by filtration before the filtrate was concentrated under reduced pressure. The residue was dissolved in CHCl 3 and insoluble material was removed by filtration before the filtrate was concentrated under reduced pressure and dried to afford 35a (1.05 g). In Chart 1, when R 1 is 3-fluorophenyl, the carboxylic acid 34 is 34a. 2-[2-(3-Fluorophenyl)-5,6-dimethyl-3-oxo-2,3-dihydro-1H-isoindol-1-yl]acetic Acid (34a) A mixture of 5,6-dimethyl-2-benzofuran-1,3-dione 30 (4.0 g, 22.7 mmol) and 3-fluoroaniline (2.5 g, 22.7 mmol) in CH 3 COOH (70 ml) was heated under reflux for 2 h and allowed to cool. The precipitate was then collected by filtration, washed with petroleum ether, and dried to afford 2-(3-fluorophenyl)-5,6-dimethyl-1H-isoindole-1,3(2H)-dione 31a (4.55 g, 74%). The obtained 31a (4.55 g, 16.9 mmol) was suspended in MeOH (70 ml) and tetrahydrofuran (70 ml) and under ice-cooling, NaBH 4 (1.28 g, 33.8 mmol) was added portionwise and stirring continued for 20 min at the same temperature. After water was added to the reaction mixture, the precipitate was collected by filtration, washed with water, and dried to afford 2-(3-fluorophenyl)-3-hydroxy-5,6-dimethylisoindolin-1-one 32a (3.25 g, 71%). The obtained 32a (3.25 g, 12 mmol) and ethyl 2-(triphenylphosphoranylidene)acetate (4.88 g, 14 mmol) in toluene (80 ml) was heated under reflux for 3.5 h under an argon atmosphere and the reaction mixture was then concentrated under reduced pressure. After the resulting residue was dissolved in CHCl 3 and passed through silica gel, the unreacted ethyl 2-(triphenylphosphoranylidene) acetate was removed by absorption to the silica gel and the filtrate was concentrated under reduced pressure. A solution of the crude residue in MeOH (40 ml) and 15% aqueous K 2 CO 3 (11 ml) was stirred at 80°C for 4 h and concentrated under reduced pressure. H 2 O was added to the residue, followed by extraction with diethyl ether. The aqueous layer was acidified with concentrated hydrochloric acid and the precipitate was collected by filtration, washed with water, and dried to afford 34a (2.36 g, 63%). In Chart 1, when R 1 is 3-pyridinyl, the hemiacetal 32 is 32b. 3-Hydroxy-5,6-dimethyl-2-(3-pyridinyl)isoindolin-1-one (32b) 5,6-Dimethyl-2-benzofuran-1,3-dione 30 (2.0 g, 11 mmol) and 3-aminopyridine (1.0 g, 11 mmol) in CH 3 COOH (30 ml) were heated under reflux for 1.5 h. After cooling, H 2 O was added and the precipitate was collected by filtration, washed with water, and dried to afford 5,6-dimethyl-2-(3-pyridinyl)-1H-isoindole-1,3(2H)-dione 31b (2.3 g, 83%) . The obtained 31b (0.5 g, 2.0 mmol) was suspended in MeOH (10 ml) and tetrahydrofuran (10 ml), and under ice-cooling NaBH 4 (75 mg, 2.0 mmol) was added portionwise then stirred at the same temperature for 30 min. To the reaction mixture, H 2 O was added then the precipitate was collected by filtration, washed with water, and dried to afford 32b (0.4 g, 79%). In Chart 1, when R 1 is 3-pyridinyl, the carboxylic acid 34 is 34b. 2-[5,6-Dimethyl-3-oxo-2-(3-pyridinyl)-2,3-dihydro-1H-isoindol-1-yl]acetic Acid (34b) A solution of 33b (0.20 g, 0.59 mmol) in MeOH (1.5 ml) and 15% aqueous K 2 CO 3 (0.46 ml) was stirred at 75°C for 4 h. The reaction mixture was concentrated under reduced pressure and H 2 O was added to the residue before the mixture was extracted with diethyl ether. The aqueous layer was acidified with concentrated hydrochloric acid and the resulting precipitate was collected by filtration, washed with water, and dried to afford 34b (0.12 g, 69% (8.4 g, 26 mmol) in MeOH (250 ml), NaBH 4 (11 g, 0.52 mol) was added portionwise, followed by stirring at 80°C for 3 h. Ice-water was added to the reaction mixture and the resulting precipitate was collected by filtration, washed with water, and dried to afford 3-(2-hydroxyethyl)-5,6-dimethyl-2-(3-pyridinyl)isoindolin-1-one 41 (6.0 g, 82%). After the obtained 41 (5.5 g, 20 mmol) was dissolved in dichloromethane (140 ml), triethylamine (5.4 ml, 29 mmol) and methanesulfonyl chloride (2.4 ml, 21 mmol) were added to it and the mixture was stirred at 25°C for 2 h then concentrated under reduced pressure. The resulting residue was chromatographed on a silica gel column (CHCl 3 /MeOHϭ 20/1) to give 42 (5.5 g, 76% 
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